Bone marrow dosimetry exploratory analysis from the phase 3 SIERRA trial of (131)I-apamistamab prior to HCT in relapsed/refractory acute myeloid leukemia Meeting Abstract
| Authors: | Pandit-Taskar, N.; Natwa, M.; Chen, M.; Leung, E.; Spross, J.; Li, K.; Desai, A.; Brodin, P.; Wahl, R. |
| Abstract Title: | Bone marrow dosimetry exploratory analysis from the phase 3 SIERRA trial of (131)I-apamistamab prior to HCT in relapsed/refractory acute myeloid leukemia |
| Meeting Title: | 2024 Annual Congress of the European Association of Nuclear Medicine (EANM'24) |
| Journal Title: | European Journal of Nuclear Medicine and Molecular Imaging |
| Volume: | 51 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Oct 19-23 |
| Meeting Location: | Hamburg, Germany |
| ISSN: | 1619-7070 |
| Publisher: | Springer |
| Date Published: | 2024-12-01 |
| Start Page: | S206 |
| Language: | English |
| ACCESSION: | WOS:001332779401008 |
| PROVIDER: | wos |
| DOI: | 10.1007/s00259-024-06838-z |
| Notes: | Meeting Abstract: EPS-134 -- Source: Wos |
